Related Experiment Video
Updated: Jun 17, 2026

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza
Published on: June 9, 2011
Subtype identification of the novel A H1N1 and other human influenza A viruses using an oligonucleotide microarray
Xiaoping Kang1, Yongqiang Li, Honghe Sun
1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Dongdajie Road 20, Fengtai District, 100071 Beijing, China.
Abstract:
A novel strain of influenza A (H1N1) virus was isolated in Mexico and the US in March and April 2009. This novel virus spread to many countries and regions in a few months, and WHO raised the level of pandemic alert from phase 5 to phase 6 on June 11, 2009. The accurate identification of H1N1 virus and other human seasonal influenza A viruses is very important for further treatment and control of their infections. In this study, we developed an oligonucleotide microarray to subtype human H1N1, H3N2 and H5N1 influenza viruses, which could distinguish the novel H1N1 from human seasonal H1N1 influenza viruses and swine H1N1 influenza viruses. The microarray utilizes a panel of primers for multiplex PCR amplification of the hemagglutinin (HA), neuraminidase (NA) and matrix (MP) genes of human influenza A viruses. The 59-mer oligonucleotides were designed to distinguish different subtypes of human influenza A viruses. With this microarray, we accurately identified and correctly subtyped the reference virus strains. Moreover, we confirmed 4 out of 39 clinical throat swab specimens from suspected cases of novel H1N1.
Insights
A new oligonucleotide microarray accurately identifies novel H1N1 influenza viruses, distinguishing them from seasonal strains. This rapid diagnostic tool is crucial for controlling the H1N1 pandemic and other influenza A infections.
Area of Science:
- Virology
- Molecular Diagnostics
- Epidemiology
Background:
- The 2009 H1N1 influenza A pandemic posed a significant global health threat.
- Accurate and rapid identification of influenza A subtypes is critical for effective treatment and control strategies.
- Distinguishing novel H1N1 from seasonal influenza strains is essential for pandemic management.
Purpose of the Study:
- To develop and validate an oligonucleotide microarray for subtyping human influenza A viruses, including the novel H1N1 strain.
- To differentiate the novel H1N1 virus from seasonal H1N1 and swine H1N1 influenza viruses.
- To assess the microarray's performance in identifying clinical cases of novel H1N1.
Main Methods:
- Development of a multiplex PCR assay targeting hemagglutinin (HA), neuraminidase (NA), and matrix (MP) genes.
- Design of 59-mer oligonucleotide probes specific for differentiating influenza A subtypes.
- Application of the oligonucleotide microarray for subtyping reference strains and clinical specimens.
Main Results:
- The developed microarray accurately identified and subtyped reference strains of human influenza A viruses.
- The assay successfully distinguished the novel H1N1 strain from seasonal H1N1 and swine H1N1 viruses.
- Four out of 39 clinical throat swab samples from suspected novel H1N1 cases were correctly identified.
Conclusions:
- The oligonucleotide microarray is a reliable tool for rapid and accurate subtyping of human influenza A viruses, including the novel H1N1 strain.
- This diagnostic platform can aid in the surveillance and control of influenza pandemics.
- The microarray shows potential for use in clinical settings for timely diagnosis of influenza infections.
Related Concept Videos
Leaky Scanning
DNA Microarrays

